Wall shear stress is decreased in the pulmonary arteries of patients with pulmonary arterial hypertension: An image-based, computational fluid dynamics study

Pulmonary Circulation

Volumn 2, Issue 4, 2012, Pages 470-476

  Tang, Beverly T ^a   Pickard, Sarah S ^b   Chan, Frandics P ^c   Tsao, Philip S ^c   Taylor, Charles A ^a   Feinstein, Jeffrey A ^a,d  

^a Stanford University   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d STANFORD UNIVERSITY   (United States)

Author keywords

Biomedical engineering; Computer simulation; Endothelium derived factors

Indexed keywords

EID: 84881514878     PISSN: 20458932     EISSN: 20458940     Source Type: Journal    
DOI: 10.4103/2045-8932.105035     Document Type: Article

References (38)

1. D’Alonzo GE, Barst RJ, Ayres SM, Bergofsky EH, Brundage BH, Detre KM, et al. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med 1991;115:343-9.
2. Walcott G, Burchell HB, Brown AL Jr. Primary pulmonary hypertension. Am J Med 1970;49:70-9.
3. Fisher AB, Chien S, Barakat AI, Nerem RM. Endothelial cellular response to altered shear stress. Am J Physiol Lung Cell Mol Physiol 2001;281:L529-33.
4. Dudek SM, Garcia JG. Cytoskeletal regulation of pulmonary vascular permeability. J Appl Physiol 2001;91:1487-500.
5. Sitbon O, Gressin V, Speich R, Macdonald PS, Opravil M, Cooper DA, et al. Bosentan for the treatment of human immunodeficiency virus-associated pulmonary arterial hypertension. Am J Respir Crit Care Med 2004;170:1212-7.
6. Giaid A, Saleh D. Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension. N Engl J Med 1995;333:214-21.
7. Giaid A, Yanagisawa M, Langleben D, Michel RP, Levy R, Shennib H, et al. Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. N Engl J Med 1993;328:1732-9.
8. Archer S, Rich S. Primary pulmonary hypertension: A vascular biology and translational research “Work in progress.” Circulation 2000;102:2781-91.
9. Botney MD. Role of hemodynamics in pulmonary vascular remodeling: Implications for primary pulmonary hypertension. Am J Respir Crit Care Med 1999;159:361-4.
10. Boutet K, Montani D, Jais X, Yaici A, Sitbon O, Simonneau G, et al. Therapeutic advances in pulmonary arterial hypertension. Ther Adv Respir Dis 2008;2:249-65.
11. Kouzu H, Nakatani S, Kyotani S, Kanzaki H, Nakanishi N, Kitakaze M. Noninvasive estimation of pulmonary vascular resistance by doppler echocardiography in patients with pulmonary arterial hypertension. Am J Cardiol 2009;103:872-6.
12. Chemla D, Castelain V, Herve P, Lecarpentier Y, Brimioulle S. Haemodynamic evaluation of pulmonary hypertension. Eur Respir J 2002;20:1314-31.
13. Segers P, Brimioulle S, Stergiopulos N, Westerhof N, Naeije R, Maggiorini M, et al. Pulmonary arterial compliance in dogs and pigs: The three-element windkessel model revisited. Am J Physiol 1999;277:H725-31.
14. Slife DM, Latham RD, Sipkema P, Westerhof N. Pulmonary arterial compliance at rest and exercise in normal humans. Am J Physiol 1990;258:H1823-8.
15. Rodes-Cabau J, Domingo E, Roman A, Majo J, Lara B, Padilla F, et al. Intravascular ultrasound of the elastic pulmonary arteries: A new approach for the evaluation of primary pulmonary hypertension. Heart 2003;89:311-5.
16. Berger RM, Cromme-Dijkhuis AH, Hop WC, Kruit MN, Hess J. Pulmonary arterial wall distensibility assessed by intravascular ultrasound in children with congenital heart disease: An indicator for pulmonary vascular disease? Chest 2002;122:549-57.
17. Fourie PR, Coetzee AR, Bolliger CT. Pulmonary artery compliance: Its role in right ventricular-arterial coupling. Cardiovasc Res 1992;26:839-44.
18. Piene H, Sund T. Does normal pulmonary impedance constitute the optimum load for the right ventricle? Am J Physiol 1982;242:H154-60.
19. Muthurangu V, Atkinson D, Sermesant M, Miquel ME, Hegde S, Johnson R, et al. Measurement of total pulmonary arterial compliance using invasive pressure monitoring and mr flow quantification during mr-guided cardiac catheterization. Am J Physiol Heart Circ Physiol 2005;289:H1301-6.
20. Hoskins PR, Hardman D. Three-dimensional imaging and computational modelling for estimation of wall stresses in arteries. Br J Radiol 2009;82:S3-17.
21. Tang BT, Fonte TA, Chan FP, Tsao PS, Feinstein JA, Taylor CA. Three-dimensional hemodynamics in the human pulmonary arteries under resting and exercise conditions. Ann Biomed Eng 2011;39:347-58.
22. Draney MT, Alley MA, Tang BT, Wilson NM, Herfkens RJ, Taylor CA. Importance of 3d nonlinear gradient corrections for quantitative analysis of 3d mr angiographic data Proceedings of the International Society for Magnetic Resonance in Medicine. Vol. 10. Tenth Scientific Meeting and Exposition; 2002.
23. Wilson NM, Wang K, Dutton RW, Taylor CA. A software framework for creating patient specific geometric models from medical imaging data for simulation based medical planning of vascular surgery. Lecture Notes in Computer Sci 2001;2208:449-56.
24. Wang KC, Dutton RW, Taylor CA. Level sets for vascular model construction in computational hemodynamics. IEEE EngMedBiol 1999;18:33-9.
25. Taylor CA, Hughes TJ, Zarins CK. Finite element modeling of blood flow in arteries. Comput Methods Appl Mech Eng 1998;158:155-96.
26. Malek AM, Izumo S, Alper SL. Modulation by pathophysiological stimuli of the shear stress-induced up-regulation of endothelial nitric oxide synthase expression in endothelial cells. Neurosurgery 1999;45:334-44.
27. Noris M, Morigi M, Donadelli R, Aiello S, Foppolo M, Todeschini M, et al. Nitric oxide synthesis by cultured endothelial cells is modulated by flow conditions. Circ Res 1995;76:536-43.
28. Fisher AB, Al-Mehdi AB, Manevich Y. Shear stress and endothelial cell activation. Crit Care Med 2002;30:S192-7.
29. Galie N, Ghofrani HA, Torbicki A, Barst RJ, Rubin LJ, Badesch D, et al. Sildenafil citrate therapy for pulmonary arterial hypertension. N Engl J Med 2005;353:2148-57.
30. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980;288:373-6.
31. Ignarro LJ, Byrns RE, Buga GM, Wood KS. Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacologic and chemical properties identical to those of nitric oxide radical. Circ Res 1987;61:866-79.
32. Murad F. The 1996 albert lasker medical research awards. Signal transduction using nitric oxide and cyclic guanosine monophosphate. JAMA 1996;276:1189-92.
33. Tzima E, Irani-Tehrani M, Kiosses WB, Dejana E, Schultz DA, Engelhardt B, et al. A mechanosensory complex that mediates the endothelial cell response to fluid shear stress. Nature 2005;437:426-31.
34. Chen BP, Li YS, Zhao Y, Chen KD, Li S, Lao J, et al. Dna microarray analysis of gene expression in endothelial cells in response to 24-h shear stress. Physiol Genomics 2001;7:55-63.
35. Garcia-Cardena G, Fan R, Shah V, Sorrentino R, Cirino G, Papapetropoulos A, et al. Dynamic activation of endothelial nitric oxide synthase by hsp90. Nature 1998;392:821-4.
36. Porreca E, Di Febbo C, Reale M, Castellani ML, Baccante G, Barbacane R, et al. Monocyte chemotactic protein 1 (mcp-1) is a mitogen for cultured rat vascular smooth muscle cells. J Vasc Res 1997;34:58-65.
37. Rieder MJ, Carmona R, Krieger JE, Pritchard KA Jr, Greene AS. Suppression of angiotensin-converting enzyme expression and activity by shear stress. Circ Res 1997;80:312-9.
38. McLaughlin VV, Genthner DE, Panella MM, Rich S. Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension. N Engl J Med 1998;338:273-7.